The role of resveratrol in cancer therapy

QR Code

The role of resveratrol in cancer therapy

© 2017 by the authors. Licensee MDPI, Basel, Switzerland. Natural product compounds have recently attracted significant attention from the scientific community for their potent effects against inflammation-driven diseases, including cancer. A significant amount of research, including preclinical, cl...

Full description

Bibliographic Details
Main Authors:	Ko, J., Sethi, G., Um, J., Shanmugam, M., Arfuso, Frank, Kumar, Alan Prem, Bishayee, A., Ahn, K.
Format:	Journal Article
Published:	MDPI AG 2017
Online Access:	http://hdl.handle.net/20.500.11937/62841

Similar Items

Triterpenoids and sesquiterpenoids for prostate cancer therapy
by: Shanmugam, M., et al.
Published: (2016)

Potential role of genipin in cancer therapy
by: Shanmugam, M., et al.
Published: (2018)

Pharmacological utilization of bergamottin, derived from grapefruits, in cancer prevention and therapy
by: Ko, J., et al.
Published: (2018)

Role of RNF20 in cancer development and progression – a comprehensive review
by: Sethi, G., et al.
Published: (2018)

NF-κB in cancer therapy
by: Li, F., et al.
Published: (2015)

Oleanolic acid and its synthetic derivatives for the prevention and therapy of cancer: Preclinical and clinical evidence
by: Shanmugam, M., et al.
Published: (2014)

Potential role of targeted therapies in the treatment of triple-negative breast cancer
by: Jia, L., et al.
Published: (2016)

Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: Potential role in prevention and therapy of cancer
by: Shanmugam, M., et al.
Published: (2012)

Modulation of diverse oncogenic transcription factors by thymoquinone, an essential oil compound isolated from the seeds of Nigella sativa Linn
by: Shanmugam, M., et al.
Published: (2017)

Modulation of diverse oncogenic transcription factors by thymoquinone, an essential oil compound isolated from the seeds of Nigella sativa Linn
by: Shanmugam, M., et al.
Published: (2018)

Possible use of Punica granatum (Pomegranate) in cancer therapy
by: Khwairakpam, A., et al.
Published: (2018)

Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer
by: Shanmugam, M., et al.
Published: (2017)

Cancer prevention and therapy through the modulation of transcription factors by bioactive natural compounds
by: Shanmugam, M., et al.
Published: (2015)

Pro-apoptotic and anti-cancer properties of diosgenin: A comprehensive and critical review
by: Sethi, G., et al.
Published: (2018)

Correction: Role of novel histone modifications in cancer [Oncotarget, 9, (2018), (11414-11426)] doi 10.18632/oncotarget.23356
by: Shanmugam, M., et al.
Published: (2018)

Ursolic acid in cancer prevention and treatment: Molecular targets, pharmacokinetics and clinical studies
by: Shanmugam, M., et al.
Published: (2013)

Role of novel histone modifications in cancer
by: Shanmugam, M., et al.
Published: (2018)

Formononetin-induced oxidative stress abrogates the activation of STAT3/5 signaling axis and suppresses the tumor growth in multiple myeloma preclinical model
by: Kim, C., et al.
Published: (2018)

Targeting transcription factor STAT3 for cancer prevention and therapy.
by: Chai, E., et al.
Published: (2015)

Colon cancer chemoresistance and chemosensitization
by: Shanmugam, M., et al.
Published: (2018)

Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy
by: Dai, X., et al.
Published: (2015)

Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer
by: Shrimali, D., et al.
Published: (2013)

Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors
by: Siveen, K., et al.
Published: (2013)

Suppression of essential pro-inflammatory signaling pathways by natural agents for the therapy of Multiple Myeloma
by: Sikka, S., et al.
Published: (2014)

Corrigendum on “Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer” [Cancer Lett. 363 (1) (2015) 28–36]
by: Manu, K., et al.
Published: (2018)

The multifaceted role of curcumin in cancer prevention and treatment
by: Shanmugam, M., et al.
Published: (2015)

Molecular targets and anti-cancer potential of escin
by: Cheong, D., et al.
Published: (2018)

The role of signal transducer and activator of transcription 3 (STAT3) and its targeted inhibition in hematological malignancies
by: Arora, L., et al.
Published: (2018)

Role of NF-κB in tumorigenesis
by: Shanmugam, M., et al.
Published: (2013)

Analysis of the intricate relationship between chronic inflammation and cancer
by: Chai, E., et al.
Published: (2015)

Multifaceted link between cancer and inflammation
by: Sethi, G., et al.
Published: (2012)

Molecular Targets of Ascochlorin and Its Derivatives for Cancer Therapy
by: Min-Wen, J., et al.
Published: (2017)

Potential anti-inflammatory and anti-cancer properties of farnesol
by: Jung, Y., et al.
Published: (2018)

Cardamonin represses proliferation, invasion, and causes apoptosis through the modulation of signal transducer and activator of transcription 3 pathway in prostate cancer
by: Zhang, J., et al.
Published: (2017)

Dysregulation of Nrf2 in hepatocellular carcinoma: Role in cancer progression and chemoresistance
by: Raghunath, A., et al.
Published: (2018)

Simvastatin sensitizes human gastric cancer xenograft in nude mice to capecitabine by suppressing nuclear factor-kappa B-regulated gene products
by: Manu, K., et al.
Published: (2013)

SREBP-1c as a molecular bridge between lipogenesis and cell cycle progression of clear cell renal carcinoma
by: Sethi, G., et al.
Published: (2017)

Key cell signaling pathways modulated by zerumbone: Role in the prevention and treatment of cancer
by: Prasannan, R., et al.
Published: (2012)

The potential role of boswellic acids in cancer prevention and treatment
by: Roy, N., et al.
Published: (2016)

Evidence for the Involvement of the Master Transcription Factor NF-?B in Cancer Initiation and Progression.
by: Puar, Y., et al.
Published: (2018)